ACP Revenue and Competitors
Estimated Revenue & Valuation
- ACP's estimated annual revenue is currently $46.6M per year.
- ACP's estimated revenue per employee is $297,000
Employee Data
- ACP has 157 Employees.
- ACP grew their employee count by 11% last year.
ACP's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Finance | Reveal Email/Phone |
2 | VP Supply Chain | Reveal Email/Phone |
3 | Director Manufacturing | Reveal Email/Phone |
4 | Director Design Engineering | Reveal Email/Phone |
5 | Director Quality | Reveal Email/Phone |
6 | Director Sales - East | Reveal Email/Phone |
7 | Director Global Chain Sales | Reveal Email/Phone |
8 | Director Marketing And Product Management | Reveal Email/Phone |
9 | Director Key Account Sales & Culinary Services | Reveal Email/Phone |
10 | Director Human Resources | Reveal Email/Phone |
ACP Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $164.7M | 488 | 2% | N/A | N/A |
#2 | $16.3M | 67 | 10% | N/A | N/A |
#3 | $870.9M | 2304 | 7% | N/A | N/A |
#4 | $29.7M | 110 | 2% | N/A | N/A |
#5 | $46.6M | 157 | 11% | N/A | N/A |
#6 | $41.6M | 140 | 3% | N/A | N/A |
#7 | $172.8M | 512 | 2% | N/A | N/A |
#8 | $4.7M | 25 | -7% | N/A | N/A |
#9 | $53.5M | 180 | 2% | N/A | N/A |
#10 | $79.3M | 267 | 6% | N/A | N/A |
What Is ACP?
ACP, Inc. manufactures and distributes commercial high speed combination ovens and microwaves under the Amana® Commercial and Menumaster® Commercial brands, two of the most recognized and respected brands in the foodservice industry. Our headquarters and manufacturing facility is in the heartland of the United States, yet our reach is global through our international distribution and our affiliation as part of The Ali Group of Foodservice Equipment Companies.
keywords:Food & BeveragesN/A
Total Funding
157
Number of Employees
$46.6M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ACP News
Shares of Acadia Pharmaceuticals Inc. were lower in Monday's late-trading session, after the company said a Phase 2 trial of its ACP-044 to...
ACP-044 is a non-opioid, novel, first in class, redox modulator investigational drug in development for the treatment of acute and chronic pain.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 159 | -1% | N/A |
#2 | $57.9M | 162 | 5% | N/A |
#3 | $59.3M | 167 | 2% | N/A |
#4 | $55.2M | 173 | 3% | N/A |
#5 | $19.5M | 177 | 5% | N/A |